ArticleEchocardiography (Mount Kisco, N.Y.)2025
Analysis of the Predictive Effect of Cardiac Color Doppler Ultrasound Combined With Carotid Ultrasound on Major Adverse Cardiac Events Following Percutaneous Coronary Intervention.
Article in Echocardiography (Mount Kisco, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Analysis of the Predictive Effect of Cardiac Color Doppler Ultrasound Combined With Carotid Ultrasound on Major Adverse Cardiac Events Following Percutaneous Coronary Intervention.Echocardiography (Mount Kisco, N.Y.) · 2025Article
Corrections and comments
- Retracted
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study sought to investigate the predictive effect of combining cardiac color Doppler ultrasound and carotid ultrasound for major adverse cardiac events (MACE) following percutaneous coronary intervention (PCI).
methodsA retrospective analysis was conducted on 475 coronary heart disease (CHD) patients who underwent PCI between May 2021 and April 2024. Cardiac ultrasound parameters (left atrial diameter [LAD], left ventricular diameter in diastole [LVDd]) and carotid ultrasound metrics (plaque score, intima-media thickness [IMT], total plaque area [TPA], and gray scale median [GSM]) were collected within 48 h post-PCI. Patients were monitored for a 12-month period to record MACE incidence. After 12 months of follow-up, patients were assigned to a Without MACE group (n = 324) and a With MACE group (n = 151). Correlation and multivariate logistic regression analyses were conducted to identify predictors, and receiver operating characteristic (ROC) curves evaluated predictive accuracy.
resultsAmong 151 patients (31.8%) who experienced MACE, significant predictors included diabetes requiring medication (OR = 1.80, p = 0.039), prior myocardial infarction (OR = 1.93, p = 0.009), elevated discharge heart rate (OR = 1.10, p = 0.013), Charlson Comorbidity Index (OR = 1.60, p = 0.002), maximum left ventricular thickness (OR = 1.181, p = 0.003), higher Tei index (OR = 1.386, p = 0.001), plaque score (OR = 5.032, p = 0.001), carotid IMT (OR = 2.216, p = 0.002), and TPA (OR = 1.039, p = 0.016). Protective factors included beta-blocker use (OR = 0.468, p = 0.027), higher LVEF (OR = 0.957, p = 0.009), and higher GSM (OR = 0.894, p = 0.045). The combined ultrasound model achieved an AUC of 0.833, demonstrating robust predictive accuracy.
conclusionCardiac color Doppler ultrasound combined with carotid ultrasound effectively predicts post-PCI MACE by integrating cardiac function and atherosclerotic plaque characteristics. These non-invasive imaging tools offer a valuable framework for early risk assessment and personalized treatment strategies in CHD patients following PCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.